Methods and devices for delivering a ventricular stent

Information

  • Patent Grant
  • 6854467
  • Patent Number
    6,854,467
  • Date Filed
    Tuesday, May 1, 2001
    24 years ago
  • Date Issued
    Tuesday, February 15, 2005
    20 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Isabella; David J.
    • Chattopadhyay; Urmi
    Agents
    • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Abstract
A method, and related tools for performing the method, of delivering a stent or other like device to the heart to connect the left ventricle to the coronary artery to thereby supply blood directly from the ventricle to the coronary artery may be used to bypass a total or partial occlusion of a coronary artery. The method may include placing a guide device and a dilation device through an anterior wall and a posterior wall of the coronary vessel and through a heart wall between the heart chamber and the coronary vessel. The dilation device may be used to form a passageway in the heart wall at a location defined by the guide device. The method may then include placing a stent within the passageway.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates to methods and related devices for forming a passageway in a heart wall and delivering a stent therein to supply oxygenated blood flow to vascular structure from a chamber of the heart. For example, the methods and related devices preferably place a stent in the left ventricular heart wall in order to establish a supply of blood from the left ventricle to the coronary artery at a point distal a partial or total occlusion of the artery.


2. Background of the Related Art


A prevalent form of heart failure involves the build-up of plaque on walls of various vascular structure, such as, for example, the coronary artery. The plaque that builds up on the walls can form either a partial or total occlusion in the artery. Such an occlusion may either limit or completely block blood flow through the artery, which typically enters through the aortic valve from the left ventricle. Because the coronary artery supplies blood to the various blood vessels within the muscle forming the heart wall, limiting or blocking of the blood flow through the coronary artery can result in damage to the heart muscle, such as, for example, necrosis. Necrotic tissue can lead to reduced cardiac function by diminishing the pumping capacity of the heart. In some instances, the diminished capacity of the heart can lead to heart attack.


Various techniques have been developed to treat this type of heart condition. For example, a surgical technique, referred to as coronary artery bypass grafting (CABG), involves removing a vein or portion thereof from the patient, usually from the femoral vein, and grafting the vein so as to connect portions of the coronary artery upstream and downstream of the occlusion. Thus, the blood flow is directed around the occlusion and through the vein graft so that the oxygenated blood can be delivered to the vessels in the heart wall. CABG generally is performed as an open surgery resulting in relatively long recovery times. Patients also often experience a large amount of discomfort resulting from harvesting of the veins to be used in CABG. Furthermore, the veins that are grafted to the coronary artery have a limited useful life.


Coronary angioplasty represents another form of treatment of arteries having occlusions that can be performed as an alternative to bypass surgery. In this technique, a balloon catheter is inserted percutaneously into the coronary artery. Once the catheter has been inserted such that the balloon is adjacent the occlusion being treated, the balloon is inflated to dilate the artery in the location of the occlusion. Often this technique involves inflating and deflating the balloon repeatedly to establish the desired dilation of the artery. This technique may include placing a stent in a collinear manner in the artery at the location of the occlusion to maintain the proper dilation of the artery. Delivery of the stent can be accomplished by removing the dilation balloon catheter and then inserting a balloon carrying the stent. A multiple balloon stent delivery catheter may dilate the artery and place the stent in a single insertion of the catheter into the patient.


Another technique that has been used to bypass a partial or total occlusion of the artery includes implanting a stent, or otherwise creating a flow passage, in the myocardial wall between the left ventricle and coronary artery at a position downstream of the occlusion. In this technique, a portion of the blood pumped from the left ventricle flows directly into the coronary artery.


SUMMARY OF THE INVENTION

The advantages and purpose of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The advantages and purpose of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.


The present invention pertains to methods, and related tools for performing the method, of delivering a stent or other like-device to the heart to connect the left ventricle to the coronary artery to thereby supply blood directly from the ventricle to the coronary artery. In a preferred embodiment, a method may be used to bypass a total or partial occlusion of a coronary artery. The inventive method is relatively quicker and less invasive than other techniques as a result, for example, of the manner in which the device is implanted into the heart and the elimination of the need to harvest veins from the patient to perform a CABG. Moreover, the delivery technique according to an embodiment of the present invention facilitates connecting the ventricle and coronary artery via a stent, the technique ultimately reducing the risk of damage to the coronary artery, as will be explained.


An aspect of the invention includes a method to provide direct blood flow between a heart chamber and a coronary vessel. The method includes placing a guide device through an anterior wall and a posterior wall of the coronary vessel and through a heart wall between the heart chamber and the coronary vessel, forming a passageway in the heart wall at a location defined by the guide device, and placing a stent within the passageway. The method may include insertion of a hollow needle through the anterior wall and the posterior wall of the coronary vessel and through the heart wall, prior to placing the guide device. The guide device may be, for example, a guidewire or other suitable like guide mechanism. According to an aspect of the invention, placing the guide device includes inserting the guidewire through the hollow needle until an end of the guidewire rests in the heart chamber. The hollow needle may be removed after inserting the guidewire through the hollow needle.


According to another aspect of the invention, the method may also include measuring a depth of insertion of the hollow needle. The measuring may be accomplished by viewing markings on the hollow needle that indicate the depth of insertion of the hollow needle or determining a pressure differential between the heart chamber and exterior the heart chamber.


The method according to another aspect of the present invention also includes avoiding intracardiac structures during insertion of the hollow needle, and placing the guide device at a predetermined angle relative to the posterior wall of the coronary vessel, which may include inserting a hollow needle at the predetermined angle through the anterior wall and the posterior wall of the coronary vessel and the heart wall, prior to placing the guide device.


In an aspect of a method of the present invention, the passageway is formed with a dilation device, such as a sheath or an inflation device, which may be in the form of a balloon for example. Forming the passageway may include inserting a balloon into the location defined by the guide device and inflating the balloon. A catheter may carry the balloon over the guide device. The balloon is preferably deflated after forming the passageway and removed from the passageway after deflation.


In another aspect of the invention, a stent is placed with an inflation device. The inflation device may be a balloon that carries the stent, and placing the stent includes inserting the balloon and the stent within the passageway and inflating the balloon. A catheter may carry the balloon and the stent over the guide device.


In another embodiment of the present invention, the passageway is formed and the stent is placed by a catheter carrying a first inflation device and a second inflation device. The first inflation device may be a first balloon and the second inflation device may be a second balloon. The catheter is inserted over the guide device so that the first balloon is positioned in the location defined by the guide device. The first balloon is inflated to form the passageway and deflated after forming the passageway. The catheter then is further inserted over the guide device so that the second balloon is positioned in the passageway. The second balloon may carry a stent. The second balloon is inflated to place the stent within the passageway.


According to another aspect, the invention includes a method of providing direct blood flow between a heart chamber and a coronary vessel that includes inserting an inflation device through an anterior wall and a posterior wall of the coronary vessel and into the heart wall, inflating the inflation device within the heart wall to form a passageway between the heart chamber and the coronary vessel, and placing a stent within the passageway. Inserting the inflation device may include inserting the inflation device over a guide device extending between the heart wall and exterior the heart chamber and the coronary vessel.


Yet another aspect of the invention includes a device for measuring the depth of penetration from an anterior wall of a coronary vessel to a heart chamber. The device includes a hollow needle defining a lumen and having a distal end and a proximal end. A depth indication mechanism is disposed on an external surface of the hollow needle and a handle is disposed on the proximal end of the needle. The handle includes an inner portion in flow communication with the hollow needle and a portion of the handle is transparent so that blood from the left ventricle that enters the handle from the lumen of the needle can be observed.


According to yet another aspect of the invention, a device for placing a stent in a heart wall comprises a delivery tool configured to deliver the stent to a location within the heart wall and a stop mechanism disposed on the delivery tool such that the stop mechanism is proximate at least one end of the stent during delivery of the stent. The stop mechanism may be configured to engage a surface to determine the placement location of the stent within the heart wall.


According to another aspect, the invention includes a device for placement in a passageway between a heart chamber and a coronary vessel. The device includes a hollow conduit and a plurality of extensions protruding from an end of the conduit. The plurality of extensions can include a pair of extensions at opposite sides of the conduit.


The foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description, serve to explain the principles of the invention.



FIG. 1 is a cross-sectional view of a heart with a stent disposed in the heart wall between the left ventricle and coronary artery downstream of an occlusion in the coronary artery;



FIG. 2 is an embodiment of a positioning tool for use in a method according to an embodiment of the present invention;



FIG. 3 is an embodiment of a double-balloon catheter for use in a method according to an embodiment of the present invention;



FIG. 4 is a device according to an embodiment of the present invention for use in accessing a heart chamber through a coronary vessel and for measuring the depth of penetration from the coronary vessel to the heart chamber;



FIG. 5 is an embodiment of a guidewire placed, according to a method of the present invention, so as to provide access to the left ventricle through the coronary artery anterior and posterior walls;



FIG. 6 is an embodiment of a catheter carrying a dilation balloon and placed, according to a method of the present invention, over the guidewire of FIG. 5 with the dilation balloon inflated to form a passageway in the heart wall between the left ventricle and coronary artery;



FIG. 7 is an embodiment of a catheter carrying a delivery balloon loaded with a stent, with the delivery balloon inflated to expand the stent and deliver the stent to the heart wall between the left ventricle and coronary artery, according to an embodiment of a method of the present invention;



FIG. 8 is another embodiment of a catheter carrying a delivery balloon loaded with a stent, with the delivery balloon extending past the ends of the stent so as to form mechanical stops upon inflation of the delivery balloon, according to a method of the present invention;



FIG. 9 is an embodiment of a double balloon catheter of the type of FIG. 3 shown with the dilation balloon inflated to form a passageway in the heart wall between the left ventricle and coronary artery, according to an embodiment of a method of the present invention; and



FIG. 10 is the embodiment of the double balloon catheter of FIG. 9 in an advanced position with the delivery balloon positioned in the heart wall and inflated to deliver the stent to the heart wall and the dilation balloon resting in the left ventricle in a deflated state, according to a method of the present invention;



FIG. 11 is an embodiment of a sheath having a mechanical stop on a distal end used to deliver a balloon catheter carrying a stent, according to a method of the present invention;



FIG. 12 is an embodiment of a sheath and a double balloon catheter having a proximal balloon configured to inflate substantially horizontally within the coronary artery to form a mechanical stop for stent delivery according to a method of the present invention;



FIG. 13 is an embodiment of a sheath and balloon catheter with a T-shaped delivery balloon for stent delivery according to a method of the present invention;



FIG. 14 is a stent having extensions at an end nearest the coronary artery, according to an embodiment of the present invention; and



FIGS. 15
a and 15b each is a myocardial passageway having the stent of FIG. 14, as seen from the coronary artery during systole and diastole, respectively.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

An aspect of the present invention includes a novel method of placing a stent within the heart wall between the left ventricle and the coronary artery to provide blood flow directly therebetween. The novel method generally includes the steps of establishing a position of a passageway between the left ventricle and the coronary artery, creating the passageway, and placing a stent in the passageway. Each of these general steps will be described in greater detail below.


Although the methods according to the invention will be described with reference to establishing direct blood flow between the left ventricle and left anterior descending coronary artery, connections between other heart structures and vessels to establish flow therebetween also are within the scope of the invention. In addition, the inventive methods may be used in other settings, aside from the heart, that require creating a passage or conduit and delivering a device into the created passage to establish direct flow communication between two volumes, especially between volumes that may be difficult to access.



FIG. 1 generally shows a cross-sectional view of a heart 10 implanted with a conduit 12, preferably in the form of a stent. As shown, conduit 12 extends between the left ventricular chamber LV and the coronary artery CA at a point downstream of an occlusion O of coronary artery CA. Conduit 12 preferably does not extend substantially into either the left ventricle LV or the coronary artery CA. The invention includes other possible connection positions between the left ventricle LV and coronary artery CA, such as, for example, an angled position of conduit 12 with respect to either the left ventricle LV or the coronary artery CA. It is important that the connection position is selected so as to avoid interference with various structures in the heart, including the papillary muscles, chordae, and mitral valve.


Once implanted, conduit 12 extends from the posterior wall 14 of the coronary artery CA to the left ventricle LV. The posterior wall 14 refers to that portion of the arterial wall that interfaces with the heart wall. The anterior wall 16 of the coronary artery refers to a portion of the arterial wall that does not interface with the heart wall. In one preferred embodiment, conduit 12 lies substantially flush with the interface between posterior wall 14 of coronary artery CA and the exterior surface of heart wall HW surrounding left ventricle LV, as negative effects may result if conduit 12 protrudes into coronary artery CA or is recessed within the myocardium. For example, if conduit 12 protrudes too far into coronary artery CA, blood flow through coronary artery CA, as well as blood flow exiting conduit 12 may become disturbed, resulting in stasis. On the other hand, if conduit 12 is recessed within the myocardium such that a space remains between conduit 12 and posterior wall 14 of the CA, the space may become occluded with tissue, thereby preventing flow into CA.


The method according to an embodiment of the present invention includes forming a passage in the heart wall and implanting a conduit 12, preferably in the form of a collapsible stent, in the passage to establish direct flow communication between the left ventricular chamber and the left anterior descending coronary artery. In a preferred method of the present invention, a first step includes providing access to the location of the heart wall at which the stent 12 will be implanted. According to the invention, access to the heart wall surrounding the left ventricle LV is obtained from outside the coronary artery CA. A hollow needle 50, shown in FIG. 4, is used to puncture the anterior wall 16 of the coronary artery. Sharpened distal end 51 of needle 50 is advanced until it punctures the posterior wall 14 of the coronary artery at a position that coincides with the location at which the stent 12 will be implanted into the heart wall surrounding the left ventricle LV. Needle 50 is then inserted into and advanced through the heart wall HW until a reflux of blood into needle 50 occurs, indicating that needle 50 has entirely traversed the heart wall and entered the left ventricle LV. At least a portion of hollow needle 50 that remains external to coronary artery CA during insertion into the left ventricle LV, for instance a portion of handle 53, should be transparent to permit observation of the reflux of blood into the needle.


Insertion of the needle should avoid damaging or otherwise interfering with critical internal cardiac structures such as, for example, the papillary muscles, chordae, the mitral valve, etc. To avoid such damage, a visualization technique may be employed either prior to insertion of the needle or concurrently with the insertion of the needle. Such visualization techniques can include, for example, the use of transesophogeal, intraventricular, intracardiac, or epicardial ultrasonic probes, or a combination thereof.


In a preferred form of the invention, the stent 12 will be implanted at an angle in the heart wall. The angle of the stent 12 to the heart wall preferably is chosen according to fluid flow analyses that seek to optimize the blood flow path from the left ventricle to the coronary artery and minimize energy losses due to poor entry and exit angles, and the like. In the case of an angularly implanted stent, hollow needle 50 also will have to enter the heart wall at the appropriate angle. To properly angle hollow needle 50, a positioning tool preferably is employed. A preferred embodiment of such a positioning tool is shown in FIG. 2. Positioning tool 20 is a hollow tube preferably made of a substantially rigid material. Positioning tool 20 includes a first portion 22 connected to a second portion 24 at a hinge 26. First portion 22 has opposite ends 28, 30, and second portion 24 has an end 32 opposing end 30 and another end not shown in FIG. 2. In use, portion 22 is inserted into the coronary artery and portion 24 extends outside of the heart with end 32 open and facing towards the posterior wall of the coronary artery and the heart wall. The user bends portion 24 relative to portion 22 at hinge 26 so that portions 22 and 24 are at an appropriate angle. The user then can insert the hollow needle through portion 24 and into the heart wall at the desired angle.


After hollow needle 50 has punctured both the anterior and posterior walls of coronary artery CA, and has traversed the heart wall to enter into left ventricle LV, it may be desirable to measure the depth of penetration of the needle and thereby determine the thickness of the heart wall from the depth of needle penetration. This determination will be used later when, for example, choosing an appropriate balloon length for forming a passage between the left ventricle and the coronary artery, and choosing an appropriate length conduit to place in the passage. Therefore, on its external surface, the needle is provided with a depth indication mechanism. A preferable depth indication mechanism includes providing graduated markings representing various lengths on a proximal end of the needle. Once the needle penetrates through the ventricular wall and into the chamber, causing a reflux of blood through the needle, the depth of penetration is measured by the marking adjacent the anterior wall of the coronary artery. To then determine the thickness of the ventricular wall, the diameter of the coronary artery at the insertion site must be subtracted from the depth of needle penetration. This coronary artery diameter may be determined preoperatively by appropriate imaging techniques. Preferably, the preoperative image will show the location of the occlusion, the appropriate location for insertion of the needle, and the coronary artery diameter at that location.


An alternative depth indication mechanism includes an indicator 52 slidably disposed on needle 50. An example of such an indicator is shown in FIG. 4. Marker 52 defines an aperture through which needle 50 is inserted. The aperture preferably is sized such that marker 52 easily, yet controllably, slides along the length of the needle. That is, the aperture preferably is sized such that marker 52 frictionally engages with the needle and thus cannot slide along the needle unless a sufficient force is applied to the marker. Marker 52 abuts the anterior wall 16 of the coronary artery CA and slides along the length of the needle as the needle is inserted into the left ventricle LV. After needle 50 is removed, the depth of penetration is indicated by measuring the length from the distal end of needle 50 to marker 52. As a further alternative, graduated markings could be provided on the needle along with the marker to assist in determining the depth of penetration. Again, the actual thickness of the ventricular wall is determined by subtracting the diameter of the coronary artery (which preferably is determined using a visualization technique, such as echocardiography for example) from the depth of penetration measurement.


As a further alternative device and method for aiding the accurate determination of the depth of needle insertion, the needle may include a suitable pressure transducer at the tip of the needle. The pressure transducer would sense the pressure of the left ventricle to accurately indicate when the needle enters the left ventricle. Once such a pressure is indicated, the depth of penetration is determined by the graduated markings on the outside of the needle, as explained above.


After hollow needle 50 has been inserted through the coronary artery CA and heart wall, and into the left ventricle LV, such that a path having the desired angle and positioning relative to internal heart structures has been created, a guidewire 60 or other suitable guide device is placed within the lumen of hollow needle 50 and extended therethrough. The guidewire 60 preferably has a tip portion which is relatively flexible while the portion of the guidewire to be positioned in the myocardium preferably is relatively stiff. After the guidewire has been extended between the left ventricular chamber LV and external to the anterior wall of the coronary artery CA, the needle can be removed by sliding it off the guidewire. The placement of guidewire 60 allows a pathway to be maintained so that the myocardium and left ventricular chamber can be accessed from outside the heart. FIG. 5 shows a suitable placement of guidewire 60 with respect to the heart after the needle has been removed.


The next step of an embodiment of the inventive method includes forming a passageway in the heart wall at the location in which stent 12 will be implanted. Preferably, the passageway will be formed using a dilation mechanism, and more preferably an inflatable dilation mechanism. The inflatable dilation mechanism can be positioned in the heart wall in a deflated configuration and then inflated to thereby dilate the heart wall, thus forming the passageway. A preferred inflatable dilation mechanism for forming such a passageway includes a balloon catheter 70, such as the one shown in FIG. 6. The balloon catheter can be fed over the guidewire with a dilation balloon 71 in a deflated condition. Thus, the catheter carrying a deflated dilation balloon advances through the anterior and posterior walls of the coronary artery and into the wall surrounding the left ventricle. The catheter may be inserted until balloon 71 resides within the heart wall. Preferably, the balloon has a length corresponding to approximately the thickness of the heart wall, and more preferably greater than or equal to the thickness of the heart wall, as measured during insertion of the hollow needle with either the measuring devices described above or through the use of utlrasound or the like. If the length of the balloon is greater than the thickness of the heart wall, the balloon may be positioned such that the excess length extends into the ventricle. The diameter of the inflated balloon is chosen so as to approximate the dimensions of the stent, for example diameter and length, that is desired in the heart wall. To facilitate positioning of the catheter, and in particular the balloon, with respect to the heart wall, a visualization technique, such as ultrasound or fluoroscopy, for example, or a mechanical mechanism, such as a mechanical stop, which may be formed by the balloon itself as will be explained shortly, may be utilized.


Once the catheter has been advanced such that dilation balloon 71 resides substantially within the heart wall, an inflation mechanism (not shown) is actuated to inflate the balloon. Balloon 71 is inflated as necessary to dilate the heart wall, causing a passageway to be formed therein, as shown in FIG. 6. The balloon preferably is made of a semi-compliant material to impart the appropriate dilation force to the heart wall. Preferably, the balloon will be inflated to a diameter corresponding to less than the maximum inflation extent of the balloon. This amount of inflation preferably will correspond to the desired dimensions, diameter and length, of the formed passageway. After dilating the heart wall and forming a passageway having desired dimensions, the balloon is deflated and removed from the passageway and the heart wall.


After removing the dilation balloon, the next step includes delivery of the stent into the as-formed passageway using a suitable delivery mechanism. In a preferred embodiment of this step, an inflatable delivery mechanism carrying the stent, such as a delivery balloon with stent 12 loaded thereon, is inserted into the passageway formed in the heart wall. Preferably, the balloon carrying the stent 12 is deflated and stent 12 is a collapsible stent that will be in a collapsed state when loaded onto the deflated delivery balloon. The stent 12 can be held in place on the delivery balloon by inflation pressure or other suitable mechanism.


As with dilation balloon 71, delivery balloon 76 (shown in FIG. 7) also will be carried by a catheter inserted over the guidewire. As will be explained shortly, the catheter carrying the delivery balloon can be either the same catheter or a different catheter than that carrying the dilation balloon. In either case, the catheter will be moved relative to the heart wall such that the stent-loaded delivery balloon is positioned within the formed passageway in the heart wall. Again, visualization techniques, such as ultrasound or fluoroscopy, for example, or a mechanical mechanism, such as a stop, for example, may be utilized in order to facilitate accurate placement of the delivery balloon, and thus stent 12, within the passageway. After the delivery balloon has been accurately positioned within the passageway, an inflation mechanism, which may be the same or different inflation mechanism used for the inflation of the dilation balloon, is actuated to inflate the delivery balloon. Upon inflation of the delivery balloon, stent 12 is expanded from its collapsed configuration. Preferably, the delivery balloon will be inflated to an extent that allows stent 12 to be fully expanded to fill the passageway created by the dilation balloon, and the inflated dimensions of the delivery balloon correspond to the full expansion of stent 12. FIG. 7 shows the delivery balloon inflated to expand stent 12 so that it fills the passageway in the heart wall.


In an embodiment of the invention, the length of delivery balloon 76 exceeds the length of stent 12 while collapsed. Stent 12 may be loaded onto the delivery balloon such that the deflated delivery balloon extends beyond each end of stent 12, and preferably at least from the proximal end of stent 12. As a result of extending beyond both ends of the stent, the balloon can expand during deployment beyond the ends of stent 12 and attain a dumbbell-like shape. In this manner, as illustrated for example in FIG. 8, by manipulation of the catheter, the proximal end 76′ of the inflated balloon can provide a mechanical stop against the posterior wall of the coronary artery so that the proximal end of stent 12 can be positioned within the passageway to lie substantially flush with the posterior wall. If the ballon also extends beyond the distal end of stent 12, the distal end 76″ of the inflated balloon also can provide a mechanical stop against the heart wall so that the distal end of stent 12 can be positioned within the passageway to lie substantially flush with the heart wall. Positioning of stent 12 substantially flush with the posterior wall of the coronary artery and the heart wall is preferable, according to one embodiment of the present invention, as was explained above to reduce the amount of stasis that occurs along the blood flow path from the left ventricle to the coronary artery and to reduce the risk of hematoma formation between the stent and the posterior artery wall.


Other embodiments of the inventive method include using a sheath as a dilation mechanism to form the passageway in the heart wall and to deliver the catheter carrying the stent to the heart wall. In embodiments using a sheath, after positioning the guide device in the desired location in the heart wall, a sheath may be advanced over the guidewire and inserted through the coronary artery and heart wall. The sheath will dilate the heart wall to form the passageway. Graduated markings may be placed on the outside of the sheath to determine the depth of penetration in the heart wall. A stent to be delivered may be preloaded on a balloon catheter and inserted over the guidewire and through the sheath to the appropriate position in the heart wall.


In conjunction with this sheath delivery technique described above, various mechanisms, as shown for example in FIGS. 11-13, either alone or in combination, may be employed to facilitate appropriate positioning of the catheter and the stent with respect to the heart wall. In these embodiments of the invention, once the sheath has been inserted in the heart wall to dilate the heart wall and form the passageway, the sheath can then be retracted from the heart wall until a distal tip of the sheath resides within the coronary artery. Referring to FIG. 11, the distal tip of a sheath 200 may include a stop mechanism, such as, for example, an expandable basket 133 surrounding the distal opening of the sheath 200. Preferably, basket 133 is self-expanding, such as a nitinol basket for example, and has a diameter ranging from approximately 2 mm to approximately 3 mm. The basket 133 positions the distal tip of the sheath 200 in the coronary artery and fixes this position by engaging with either the posterior or anterior walls of the coronary artery to prevent sheath 200 from passing therethrough. Once the sheath 200 is positioned, the stent may be delivered to the heart wall by placing stent 12 just distal to the tip of sheath 200. The distance between the distal tip of sheath 200, positioned at the inner surface of the posterior wall of the coronary artery, and the top of stent 12 may be determined by graduated markings on a portion of a balloon catheter 132 carrying stent 12 and extending outside sheath 200.


After appropriate positioning of stent 12, a locking mechanism (not shown) on sheath 200 may be used to fix the position of catheter 132. Once stent 12 has been placed within the heart wall, sheath 200 and catheter 132 may be removed from the heart. To remove sheath 200, basket 133 first must be retracted or compressed.



FIG. 12 illustrates another mechanism which may be employed to facilitate the positioning of stent 12 within the heart wall. In this embodiment, after sheath 200 is inserted into the coronary artery, a double balloon catheter 142 is inserted over guidewire 60 and through sheath 200. Double balloon catheter 142 includes a distal balloon 143 carrying stent 12 and a smaller proximal balloon 144 that serves as a mechanical stop mechanism. Proximal balloon 144 preferably has a diameter ranging from approximately 2 mm to approximately 3 mm. Once balloon catheter 142 is inserted such that proximal balloon 144 is past the distal tip of sheath 200, proximal balloon 144 may be inflated. This inflation causes proximal balloon 144 to expand substantially in a horizontal direction past the distal opening of the sheath and to engage the anterior and posterior walls of the coronary artery. This holds the balloon catheter 142 in an appropriate position to place stent 12 within the heart wall. Distal balloon 143 can then be inflated to deliver stent 12. By positioning the distal end of proximal balloon 144 adjacent the posterior coronary artery wall and knowing the distance between the distal end of proximal balloon 144 and the proximal end of stent 12 on distal balloon 143, the depth of insertion within the heart wall may be determined.



FIG. 13 depicts the use of a T-shaped balloon in conjunction with a sheath delivery technique to assist in accurate positioning of stent 12 in the heart wall. In this embodiment, a balloon catheter 152 has a single T-shaped balloon 153, with stent 12 being carried by the lower, vertically-extending portion of the balloon 153. Sheath 200 is inserted, as described above, until the distal tip reaches the interior of the coronary artery. Balloon catheter 152 carrying stent 12 then is inserted through sheath 200 and over guidewire 60 until the upper, horizontally-extending portion 153a of balloon 153 is past the distal tip of sheath 200 and is within the coronary artery. Inflating balloon 153 at this point creates a mechanical stop mechanism similar to small proximal balloon 144 discussed above. That is, the upper, horizontally-extending portion 153a of T-shaped balloon 153 engages with at least the posterior wall of the coronary artery to appropriately position the lower, vertically-extending portion 153b of balloon 153, and thus stent 12, within the heart wall. Once stent 12 has been delivered and placed within the heart wall, balloon 153 can be deflated and catheter 152 and sheath 200 removed.


Regardless of the delivery technique employed, stent 12 preferably will be selected such that, upon full expansion, the conduit will have dimensions that cause the passageway in the heart wall to remain open, thereby creating a permanent passageway between the left ventricle and the coronary artery. Moreover, stent 12 preferably will have a length that approximately equals or is greater than the thickness of the heart wall. More preferably, the length of stent 12 is large enough to allow a small end portion of stent 12 to reside in the left ventricular chamber in order to prevent invagination of the tissue around the opening of the stent. Even more preferably, the length of the stent may be chosen such that it covers the systolic depth of the heart wall measured from the posterior wall of the coronary artery to the inner surface of the left ventricular wall. This systolic depth may be determined using visualization techniques, such as echocardiography, for example. In any case, the length of the stent 12 to be used may be determined from the measurements of the heart wall determined previously, for example using the hollow needle, in combination with the determination of the coronary artery diameter using appropriate visualization techniques.


In addition, the stent preferably will be made of or coated internally with a material that prevents heart wall tissue, blood, and debris from prolapsing into the stent. Such a material may include a woven or a non-woven polymer that is compatible with blood and has low thrombogenicity, or other coatings to improve resistance to thrombus formation or tissue overgrowth. Coatings that enhance endothelial cell formation also are desired. Moreover, the stent may include a drug delivery coating. Other materials exhibiting these characteristics while also allowing deployment by the inventive method also are within the scope of the invention.


A further preferable feature of the stent to be implanted in the heart wall includes a flow controller disposed within the stent. Such a flow controller preferably would bias flow in the net forward direction, i.e., in the direction flowing from the ventricle to the coronary artery. Flow control mechanisms of this type include autologous vein sections, xenograft vein or valve sections, tilting disks, ball-in-cage valves, tapered shunt configurations, lobed duckbill flaps, mechanical poppets, pressure or electrically activated valves, and other suitable like mechanisms. Examples of various flow control mechanisms used with stents to create a net forward flow from the left ventricle to the coronary artery can be found in commonly-owned U.S. patent application Ser. No. 09/368,393, filed Aug. 4, 1999, and entitled “Valve Designs for Left Ventricular Conduits.” The entire disclosure of that application is incorporated by reference herein.


In another embodiment of a flow controller, a stent may be used to create a natural valving mechanism to reduce the potential occurrence of backflow of blood from the coronary artery to the left ventricle during portions of the cardiac cycle, particularly diastole. This will be described in connection with FIGS. 14, 15a, and 15b. To create a natural valving mechanism, stent 12 may include a pair of extensions, or struts 100, extending beyond the end of the stent nearest the posterior wall 14 of the coronary artery CA, as shown in FIG. 14. Struts 100 preferably are approximately 180° apart from each other and each strut 100 may have a length of approximately 0.5 mm to approximately 1 mm. Struts 100 may be formed by removing portions of a stent between the struts or by any other suitable manner known in the art. Additional struts, or different placements or lengths of the struts, may be used. The stent used for creating a valving mechanism may be with or without additional struts as needed to keep the oval-shaped opening shown in FIGS. 15a and 15b patent. In addition, the stent may be placed so that the portion of the stent (not including the struts) ends somewhat below the posterior wall 14 of the coronary artery CA, particularly during the diastolic phase of the cardiac cycle.


This placement of the stent, along with the struts 100, causes natural valving to occur, as described with reference to FIGS. 15a and 15b. These Figures depict the passageway containing stent 12 in the heart wall, as viewed from the coronary artery looking into the passageway. FIG. 15a shows the circular shape of that passageway during systole, and the position of struts 100. The arrows in FIG. 15a depict the opening of the top of the passageway at the posterior wall of the coronary artery caused by the flow of blood from the left ventricle to the coronary artery. FIG. 15b shows an oval shape of the end of the passageway nearest the coronary artery during diastole. The posterior wall of the artery flattens out around struts 100 due to a drop in diastolic pressure as compared to normal conditions because of the placement of the stent 12. This causes the coronary artery to collapse during diastole, in turn causing the oval-shaped opening of the end of the stent disposed nearest the coronary artery as shown by the arrows in FIG. 15b. Thus, the depth of stent 12 being somewhat below the posterior wall of the coronary artery, in combination with struts 100 extending into the coronary artery, permits that posterior wall to at least partially close the passageway in the heart wall during diastole, restricting flow of blood back into the left ventricle from the coronary artery. In contrast, relatively rapid and extensive pressure rise during systole occurs due to increasing flow from the ventricular side. This causes the opening of the passage nearest the coronary artery to open to the position shown in FIG. 15a. It may also be preferable in certain embodiments to include a natural valve mechanism, like that shown in FIGS. 14-15b, at the end of the stent nearest the left ventricle.


Once stent 12 has been expanded and positioned in the passageway in the heart wall, the delivery balloon is deflated. The catheter carrying the delivery balloon can then be removed from the patient by sliding it over the guidewire. The guidewire also can be removed from the patient and the puncture site in the artery can be closed via conventional suturing methods and/or surgical sealants, or other suitable closure techniques and mechanisms. In certain embodiments, a closing device similar to those used and known to close a patent foramen ovale may be used. Also, the inner part of the closing device which covers the inner surface of the coronary artery may be constructed without any Dacron or covering material as long as the fixation of the closing device is maintained by suitable fixation members. An outer portion of the closing device, made for example of a biocompatible covering material like Dacron, may then be connected to the inner portion of the closing device to close the hole.


Alternatively, it may be possible to close the hole in the anterior wall of the artery by retracting the wall of the artery without any closing device. Such a technique would be similar to using a suture, but would not require assistance by the surgeon. For example, as the hole in the artery is formed by introducing a sheath over a wire, the tissue surrounding the hole is compressed around the sheath. After removing the sheath, this tissue will tend to cause a portion of the artery wall to retract to close the hole. To assist in this process, a small outer ring may be fixed to the outside surface of the artery. This outer ring may be formed of a suitable closure material, such as a suture or glue. The ring may be applied prior to removing the sheath, essentially using the outer surface of the sheath as an applicator. Once the ring is fixed to the outer surface of the coronary artery, the sheath may be removed. The ring may then retract the tissue surrounding the hole to close the hole in the coronary artery.


As discussed above, the steps of dilating the heart wall using a balloon catheter to form the passageway and implanting the conduit can be performed by using separate catheters for each step, a first catheter carrying the dilation balloon and a second catheter carrying the delivery balloon and stent. As an alternative, a single catheter carrying both a delivery balloon and a dilation balloon and stent in a collinear manner may be used. If two separate catheters are employed, one carrying the dilation balloon and one carrying the delivery balloon, a catheter exchange technique is employed. That is, after the catheter carrying the dilation balloon has been employed to form the passageway in the heart wall, the dilation balloon will be deflated and the catheter will be slid along the guidewire and removed from the patient. Then, the catheter carrying the delivery balloon with the collapsed stent loaded thereon is inserted over the guidewire and into the correct position with respect to the heart wall, and the conduit is implanted as described above.


If a single catheter carrying both the dilation and the delivery balloons is employed, the method is performed in the following manner. FIG. 3 shows an embodiment of such a catheter 40 having at least two colinear balloons, a first dilation balloon 42 at a distal end and a second delivery balloon 44 just proximal of dilation balloon 42. FIG. 3 shows just the distal end of catheter 40. Both balloons are connected to suitable inflation mechanisms known in the art. The same inflation mechanism can be used to inflate both balloons or two separate inflation mechanisms can be used. A suitable, exemplary length of each balloon is approximately 30 mm, and a suitable, exemplary diameter of each balloon is approximately 2.5-3.5 mm. The deflated delivery balloon 44 is loaded with the stent, not shown in FIG. 3. The catheter 40 is inserted over the guidewire and advanced until the dilation balloon 42 resides within the heart wall in the manner described above with reference to the discussion of the deployment of the dilation balloon to form the passageway. Once properly positioned within the heart wall, the dilation balloon 42 is inflated to form the passageway, as shown in FIG. 9. After the passageway has been formed, the dilation balloon 42 is deflated and the catheter is further advanced until the delivery balloon 44 is positioned within the passageway, also as discussed above. In this position, the portion of the catheter 40 carrying the deflated dilation balloon 42 will come to a rest in the left ventricular chamber. To implant the stent in the passageway, the delivery balloon 44 is inflated, causing expansion of the stent to fill the passageway, as shown in FIG. 10. Once the stent expands so as to be in contact with the heart wall surrounding the passageway, the delivery balloon 44 is deflated and the entire catheter 40 removed from the patient. The guidewire can be removed as well, leaving only the stent remaining to form a permanent passageway between the coronary artery and the left ventricle. The multiple balloon catheter shown in FIGS. 4, 9, and 10 may incorporate a delivery balloon of the type shown in FIG. 8.


In one aspect of the invention, the method includes using a multiple balloon stent delivery catheter of the type shown in FIG. 3 to perform the dilation of the heart wall to form the passageway and the implantation of the stent in a single insertion of the catheter over the guidewire, as just described. Suitable multiple balloon stent delivery catheters are disclosed in U.S. Pat. No. 4,763,654 issued to Jang and entitled “Tandem Independently Inflatable/Deflatable Multiple Diameter Balloon Angioplasty Catheter System and Method of Use” and U.S. Pat. No. 5,725,535 issued to Hedge et al. and entitled “Multiple Balloon Stent Delivery Catheter and Method.” The complete disclosures of these patents are incorporated by reference herein. The disclosed catheters include a distal balloon and inner and outer concentric balloons located proximal the distal balloon. In the method according to the present invention, the distal balloon is used to form the passageway by dilating the heart wall. The stent in a collapsed configuration can be loaded onto the outer concentric balloon, and the concentric balloons can be used to deliver the stent into the passageway by inflating either one of the inner and outer balloons or both the inner and outer balloons consecutively. In this catheter, the outer balloon is configured to expand to a greater extent than the inner balloon. However, the inner balloon may be configured to expand a to an extent large enough that allows the outer balloon, and thus the stent, to expand such that the stent fits the passageway formed by the distal, dilation balloon. The outer concentric balloon can optionally be inflated to further expand the stent and the passageway formed by the distal, delivery balloon if such expansion is needed.


Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. The specification and examples are exemplary only, with a true scope and spirit of the invention being indicated by the following claims.

Claims
  • 1. A method of treating a heart, the method comprising the steps of: placing a guidewire through an anterior wall and a posterior wall of a coronary vessel and through a heart wall between a heart chamber and the coronary vessel; advancing catheter carrying a stent along the guidewire through the anterior wall and the posterior wall of the coronary vessel and into the heart wall; and expanding the stent within the heart wall.
  • 2. The method of claim 1, further comprising forming a passageway in the heart wall at a location defined by the guidewire.
  • 3. The method of claim 2, wherein forming the passageway includes providing a dilation mechanism at the location defined by the guidewire.
  • 4. The method of claim 3, wherein the dilation mechanism includes a sheath.
  • 5. The method of claim 3, wherein forming the passageway further includes expanding the dilation mechanism.
  • 6. The method of claim 5, wherein the expanding the dilation mechanism includes inflating the dilation mechanism.
  • 7. The method of claim 2, further comprising delivering via the guidewire a first mechanism for forming the passageway in the heart wall and a second mechanism for placing the stent within the passageway.
  • 8. The method of claim 7, wherein the first and second mechanisms are delivered via the guidewire to the heart simultaneously.
  • 9. The method of claim 7, wherein the first mechanism is delivered via the guidewire to the heart and, after the first mechanism is removed from the heart via the guidewire, the second mechanism is delivered via the guidewire to the heart.
  • 10. The method of claim 7, wherein the second mechanism includes a stop mechanism and wherein the method further comprises advancing the stent within the passageway until the stop mechanism engages one of a wall of the coronary vessel and a surface of the heart wall.
  • 11. The method of claim 10, wherein the stent is advanced until the stop mechanism engages the posterior wall of the coronary vessel.
  • 12. The method of claim 11, wherein the stop mechanism is located at substantially a proximal end of the stent during the delivery of the stent.
  • 13. The method of claim 7, wherein the first mechanism includes a stop mechanism and delivering the first mechanism includes engaging the stop mechanism with at least one inner wall of the coronary vessel.
  • 14. The method of claim 13, wherein engaging the stop mechanism includes expanding the stop mechanism.
  • 15. The method of claim 2, wherein forming the passageway includes inserting a sheath into the location defined by the guidewire.
  • 16. The method of claim 2, wherein forming the passageway includes inserting a balloon into the location defined by the guidewire and inflating the balloon.
  • 17. The method of claim 16, wherein inserting the balloon includes inserting a catheter carrying the balloon over the guidewire.
  • 18. The method of claim 16, further comprising deflating the balloon after forming the passageway, and removing the balloon from the passageway after deflating the balloon.
  • 19. The method of claim 2, wherein the passageway is formed and the stent is delivered by the catheter carrying a first expansion device and a second expansion device.
  • 20. The method of claim 19, wherein the first and second expansion devices include inflation devices.
  • 21. The method of claim 20, wherein the first inflation device is a first balloon and the second inflation device is a second balloon.
  • 22. The method of claim 21, further comprising inserting the catheter over the guidewire so that the first balloon is positioned in the location.
  • 23. The method of claim 22, further comprising inflating the first balloon to form the passageway.
  • 24. The method of claim 23, further comprising deflating the first balloon after forming the passageway, and further inserting the catheter over the guidewire so that the second balloon is positioned in the passageway.
  • 25. The method of claim 24, wherein the second balloon carries the stent, and further comprising inflating the second balloon to place the stent within the passageway.
  • 26. The method of claim 22, wherein the second balloon is positioned within the coronary vessel when the first balloon is positioned at the location.
  • 27. The method of claim 26, further comprising inflating the second balloon so that the second balloon engages at least one interior wall of the coronary vessel and inflating the first balloon, the first balloon carrying the stent.
  • 28. The method of claim 2, wherein the step of forming the passageway is prior to the step of advancing the stent.
  • 29. The method of claim 2, wherein the step of forming the passageway is prior to the step of expanding the stent.
  • 30. The method of claim 2, wherein expanding the stent includes expanding the stent in the passageway.
  • 31. The method of claim 2, wherein advancing the stent includes placing the stent in the passageway.
  • 32. The method of claim 1, wherein the stent is a collapsible stent.
  • 33. The method of claim 1, further comprising measuring a distance from the anterior wall of the coronary vessel to the heart chamber prior to placing the guide device.
  • 34. The method of claim 1, further comprising the step of inserting a hollow needle through the anterior wall and the posterior wall of the coronary vessel and the heart wall, prior to placing the guidewire.
  • 35. The method of claim 34, wherein the step of placing the guidewire includes inserting the guidewire through the hollow needle until an end of the guidewire rests in the heart chamber.
  • 36. The method of claim 35, further comprising the step of removing the hollow needle after inserting the guidewire through the hollow needle.
  • 37. The method of claim 34, further comprising the step of measuring a depth of insertion of the hollow needle.
  • 38. The method of claim 37, wherein the measuring step includes viewing markings on the hollow needle, the markings indicating the depth of insertion of the hollow needle.
  • 39. The method of claim 38, further comprising determining the thickness of the heart wall by subtracting a diameter of the coronary vessel from the distance measured by the needle, and selecting said stent based on the heart wall thickness.
  • 40. The method of claim 34, further comprising avoiding intracardiac structures during insertion of the hollow needle.
  • 41. The method of claim 1, further comprising placing the guidewire at a predetermined angle relative to the posterior wall of the coronary vessel.
  • 42. The method of claim 41, wherein placing the guidewire at a predetermined angle includes inserting a hollow needle at the predetermined angle through the anterior wall and the posterior wall of the coronary vessel and the heart wall, prior to placing the guidewire.
  • 43. The method of claim 1, wherein expanding the stent includes expanding the stent with an expansion device.
  • 44. The method of claim 43, wherein the expansion device includes an inflation device.
  • 45. The method of claim 44, wherein the inflation device is a balloon that carries the stent, and expanding the stent includes inserting the balloon and the stent within the heart wall and inflating the balloon.
  • 46. The method of claim 43, wherein inserting the balloon and the stent includes inserting the catheter carrying the balloon and the stent over the guidewire.
  • 47. The method of claim 1, further comprising advancing the stent within the heart wall until a stop mechanism engages the posterior wall of the coronary vessel.
  • 48. The method of claim 47, wherein the stop mechanism is provided proximate a proximal end of the stent.
  • 49. The method of claim 1, further comprising engaging a stop mechanism with at least one interior wall of the coronary vessel.
  • 50. The method of claim 1, further comprising placing the stent in the heart wall so as to permit blood to flow between the heart chamber and the coronary vessel via the stent.
  • 51. The method of claim 50, wherein the heart chamber is a left ventricle.
  • 52. The method of claim 51, wherein the coronary vessel is a coronary artery.
  • 53. A method of treating a heart, the method comprising: inserting a needle through an anterior wall and a posterior wall of a coronary vessel; after inserting the needle, piecing a guidewire through the needle past the anterior wall and the posterior wall of the coronary vessel and through a heart wall between a heart chamber and the coronary vessel; inserting an expansion device along the guidewire through the anterior wall and the posterior wall of the coronary vessel and into the heart wall; expanding the expansion device within the heart wall to form a passageway between the heart chamber and the coronary vessel; and placing a stent within the passageway.
  • 54. The method of claim 53, wherein the stent is collapsible and placing the stent within the passageway includes delivering the stent to the passageway in a collapsed configuration and then expanding the stent within the passageway.
  • 55. The method of claim 54, wherein delivering the stent includes providing an inflatable delivery mechanism onto which the stent is loaded and expanding the stent includes inflating the delivery mechanism.
  • 56. The method of claim 53, wherein the expansion device includes a first expandable mechanism and a second expandable mechanism, and expanding the first expandable mechanism forms the passageway and expanding the second expandable mechanism places the stent within the passageway.
  • 57. The method of claim 56, wherein the first and second expandable mechanisms are inflatable mechanisms and the expanding the first and second expandable mechanisms includes inflating the first and second expandable mechanisms.
  • 58. The method of claim 53, further comprising determining the thickness of the heart wall prior to inserting the expansion device, wherein the stent is selected based on the thickness of the heart wall.
  • 59. The method of claim 53, wherein the step of placing the guidewire includes placing the guidewire through the hollow needle until an end of the guidewire rests in the heart chamber.
  • 60. The method of claim 59, further comprising the step of removing the hollow needle after inserting the guidewire through the hollow needle.
  • 61. The method of claim 53, further comprising the step of measuring a depth of insertion of the hollow needle.
  • 62. The method of claim 53, further comprising avoiding intracardiac structures during insertion of the hollow needle.
  • 63. The method of claim 53, wherein the expansion device is a balloon catheter and inserting the expansion device includes advancing the catheter over the guidewire until a distal balloon at a distal end of the balloon catheter is within the heart wall.
  • 64. The method of claim 63, wherein the balloon catheter includes the distal balloon and a proximal balloon, and inflating the distal balloon forms the passageway and inflating the proximal balloon places the stent within the passageway.
  • 65. The method of claim 64, further comprising, after forming the passageway, deflating the distal balloon and advancing the balloon catheter so that the distal balloon rests in the left ventricle and the proximal balloon is in the passageway.
  • 66. The method of claim 64, wherein the stent is loaded on the proximal balloon in a collapsed configuration and inflating the proximal balloon expands the stent and places the stent within the passageway.
  • 67. The method of claim 63, wherein the stent is placed by a second catheter carrying a second expansion device.
  • 68. The method of claim 67, wherein the second expansion device is a balloon and the balloon is inflated to place the stent.
  • 69. The method of claim 67, wherein the balloon catheter is removed after the passageway is formed and then the second catheter is inserted into the formed passageway to place the stent.
  • 70. The method of claim 53, wherein inserting the expansion device includes inserting the expansion device over the guidewire extending between the heart wall and exterior the heart chamber and the coronary vessel.
  • 71. The method of claim 53, further comprising placing the stent in the heart wall so as to permit blood to flow between the heart chamber and the coronary vessel via the stent.
  • 72. The method of claim 71, wherein the heart chamber is a left ventricle.
  • 73. The method of claim 72, wherein the coronary vessel is a coronary artery.
  • 74. A method of treating a heart, the method comprising the steps of: inserting a needle through an anterior wall and a posterior wall of a coronary vessel; after inserting the needle, placing a guidewire through the needle pas the anterior wall and posterior wall of the coronary vessel and through a heart wall between a heart chamber and the coronary vessel; advancing a stent along the guidewire through the anterior wall and the posterior wall of the coronary vessel and into the heart wall; and expanding the stent within the heart wall.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefits of U.S. Provisional Patent Application Ser. No. 60/201,732, filed May 4, 2000.

US Referenced Citations (366)
Number Name Date Kind
3971363 Fletcher et al. Jul 1976 A
4503568 Madras Mar 1985 A
4733665 Palmaz Mar 1988 A
4769029 Patel Sep 1988 A
4953553 Tremulis Sep 1990 A
4995857 Arnold Feb 1991 A
5035702 Taheri Jul 1991 A
5135467 Citron Aug 1992 A
5190058 Jones et al. Mar 1993 A
5193546 Shaknovich Mar 1993 A
5226889 Sheiban Jul 1993 A
5258008 Wilk Nov 1993 A
5287861 Wilk Feb 1994 A
5292309 Van Tassel et al. Mar 1994 A
5330486 Wilk Jul 1994 A
5344426 Lau et al. Sep 1994 A
5385541 Kirsch et al. Jan 1995 A
5389096 Aita et al. Feb 1995 A
5409019 Wilk Apr 1995 A
5423744 Gencheff et al. Jun 1995 A
5423851 Samuels Jun 1995 A
5429144 Wilk Jul 1995 A
5443497 Venbrux Aug 1995 A
5456694 Marin et al. Oct 1995 A
5456712 Maginot Oct 1995 A
5456714 Owen Oct 1995 A
5470320 Tiefenbrun et al. Nov 1995 A
5527337 Stack et al. Jun 1996 A
5554119 Harrison et al. Sep 1996 A
5578075 Dayton Nov 1996 A
5593434 Williams Jan 1997 A
5609626 Quijano et al. Mar 1997 A
5611778 Brinon Mar 1997 A
5618299 Khosravi et al. Apr 1997 A
5643278 Wijay Jul 1997 A
5655548 Nelson et al. Aug 1997 A
5662124 Wilk Sep 1997 A
5676670 Kim Oct 1997 A
5733267 Del Toro Mar 1998 A
5755682 Knudson et al. May 1998 A
5758663 Wilk et al. Jun 1998 A
5797920 Kim Aug 1998 A
5797933 Snow et al. Aug 1998 A
5807384 Mueller Sep 1998 A
5810836 Hussein et al. Sep 1998 A
5810871 Tuckey et al. Sep 1998 A
5824038 Wall Oct 1998 A
5824071 Nelson et al. Oct 1998 A
5830222 Makower Nov 1998 A
5843163 Wall Dec 1998 A
5851232 Lois Dec 1998 A
5855597 Jayaraman Jan 1999 A
5865723 Love Feb 1999 A
5876373 Giba et al. Mar 1999 A
5876419 Carpenter et al. Mar 1999 A
5878751 Hussein et al. Mar 1999 A
5885259 Berg Mar 1999 A
5893848 Negus et al. Apr 1999 A
5908028 Wilk Jun 1999 A
5908029 Knudson et al. Jun 1999 A
5922022 Nash et al. Jul 1999 A
5925012 Murphy-Chutorian et al. Jul 1999 A
5931848 Saadat Aug 1999 A
5935119 Guy et al. Aug 1999 A
5935161 Robinson et al. Aug 1999 A
5935162 Dang Aug 1999 A
5938632 Ellis Aug 1999 A
5944019 Knudson et al. Aug 1999 A
5961548 Shmulewitz Oct 1999 A
5968093 Kranz Oct 1999 A
5971993 Hussein et al. Oct 1999 A
5976153 Fischell et al. Nov 1999 A
5976155 Foreman et al. Nov 1999 A
5976159 Bolduc et al. Nov 1999 A
5976169 Imran Nov 1999 A
5976181 Whelan et al. Nov 1999 A
5976182 Cox Nov 1999 A
5976192 McIntyre et al. Nov 1999 A
5976650 Campbell et al. Nov 1999 A
5979455 Maginot Nov 1999 A
5980530 Willard et al. Nov 1999 A
5980533 Holman Nov 1999 A
5980548 Evans et al. Nov 1999 A
5980551 Summers et al. Nov 1999 A
5980552 Pinchasik et al. Nov 1999 A
5980553 Gray et al. Nov 1999 A
5980566 Alt et al. Nov 1999 A
5984955 Wisselink Nov 1999 A
5984956 Tweden et al. Nov 1999 A
5984963 Ryan et al. Nov 1999 A
5984965 Knapp et al. Nov 1999 A
5989207 Hughes Nov 1999 A
5989263 Shmulewitz Nov 1999 A
5989287 Yang et al. Nov 1999 A
5993481 Marcade et al. Nov 1999 A
5993482 Chuter Nov 1999 A
5997525 March et al. Dec 1999 A
5997563 Kretizers Dec 1999 A
5997573 Quijano et al. Dec 1999 A
5999678 Murphy-Chutorian et al. Dec 1999 A
6001123 Lau Dec 1999 A
6004261 Sinofsky et al. Dec 1999 A
6004347 McNamara et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6007543 Ellis et al. Dec 1999 A
6007575 Samuels Dec 1999 A
6007576 McClellan Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6010530 Goicoechea Jan 2000 A
6017365 Van Oepen Jan 2000 A
6026814 LaFontaine et al. Feb 2000 A
6029672 Vanney et al. Feb 2000 A
6035856 LaFontaine et al. Mar 2000 A
6036677 Javier, Jr. et al. Mar 2000 A
6036697 DiCaprio Mar 2000 A
6039721 Johnson et al. Mar 2000 A
6042581 Ryan et al. Mar 2000 A
6045565 Ellis et al. Apr 2000 A
6053911 Ryan et al. Apr 2000 A
6053924 Hussein Apr 2000 A
6053942 Eno et al. Apr 2000 A
6056743 Ellis et al. May 2000 A
6067988 Mueller May 2000 A
6068638 Makower May 2000 A
6071292 Makower et al. Jun 2000 A
6076529 Vanney et al. Jun 2000 A
6080163 Hussein et al. Jun 2000 A
6080170 Nash et al. Jun 2000 A
6092526 LaFontaine et al. Jul 2000 A
6093166 Knudson et al. Jul 2000 A
6093177 Javier, Jr. et al. Jul 2000 A
6093185 Ellis et al. Jul 2000 A
6095997 French et al. Aug 2000 A
6102941 Tweden et al. Aug 2000 A
6106538 Shiber Aug 2000 A
6110201 Quijano et al. Aug 2000 A
6113630 Vanney et al. Sep 2000 A
6113823 Eno Sep 2000 A
6117165 Becker Sep 2000 A
6120520 Saadat et al. Sep 2000 A
6123682 Knudson et al. Sep 2000 A
6126649 Van Tassel et al. Oct 2000 A
6126654 Giba et al. Oct 2000 A
6132451 Payne et al. Oct 2000 A
6139541 Vanney et al. Oct 2000 A
6152141 Stevens et al. Nov 2000 A
6155264 Ressemann et al. Dec 2000 A
6156031 Aita et al. Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6159225 Makower Dec 2000 A
6162245 Jayaraman Dec 2000 A
6165185 Shennib et al. Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6171251 Mueller et al. Jan 2001 B1
6171303 Ben-Haim et al. Jan 2001 B1
6182668 Tweden et al. Feb 2001 B1
6186972 Nelson et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6193726 Vanney Feb 2001 B1
D438618 Solem Mar 2001 S
6196230 Hall et al. Mar 2001 B1
6197050 Eno et al. Mar 2001 B1
6197324 Crittenden Mar 2001 B1
6200310 Ben-Haim et al. Mar 2001 B1
6200311 Danek et al. Mar 2001 B1
6203556 Evans et al. Mar 2001 B1
6213126 LaFontaine et al. Apr 2001 B1
6214041 Tweden et al. Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217549 Selmon et al. Apr 2001 B1
6217575 DeVore et al. Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6223752 Vanney et al. May 2001 B1
6224584 March et al. May 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235000 Milo et al. May 2001 B1
6237607 Vanney et al. May 2001 B1
6238406 Ellis et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6248112 Gambale et al. Jun 2001 B1
6250305 Tweden Jun 2001 B1
6251079 Gambale et al. Jun 2001 B1
6251116 Shennib et al. Jun 2001 B1
6251418 Ahern et al. Jun 2001 B1
6253768 Wilk Jul 2001 B1
6253769 LaFontaine et al. Jul 2001 B1
6254564 Wilk et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6258119 Hussein et al. Jul 2001 B1
6261304 Hall et al. Jul 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6283983 Makower et al. Sep 2001 B1
6285903 Rosenthal et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6290709 Ellis et al. Sep 2001 B1
6290719 Garberoglio Sep 2001 B1
6290728 Phelps et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6302892 Wilk Oct 2001 B1
6322548 Payne et al. Nov 2001 B1
6330884 Kim Dec 2001 B1
6331178 Loeb et al. Dec 2001 B1
6344027 Goll Feb 2002 B1
6350248 Knudson et al. Feb 2002 B1
6352543 Cole Mar 2002 B1
6361519 Knudson et al. Mar 2002 B1
6363938 Saadat et al. Apr 2002 B2
6363939 Wilk Apr 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6379319 Garibotto et al. Apr 2002 B1
6387119 Wolf et al. May 2002 B2
6390098 LaFontaine et al. May 2002 B1
6395208 Herweck et al. May 2002 B1
6402740 Ellis et al. Jun 2002 B1
6406488 Tweden et al. Jun 2002 B1
6406491 Vanney Jun 2002 B1
6409697 Eno et al. Jun 2002 B2
6409751 Hall et al. Jun 2002 B1
6416490 Ellis et al. Jul 2002 B1
6423089 Gingras et al. Jul 2002 B1
6432119 Saadat Aug 2002 B1
6432126 Gambale et al. Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6432132 Cottone et al. Aug 2002 B1
6443158 LaFontaine et al. Sep 2002 B1
6447522 Gambale et al. Sep 2002 B2
6447539 Nelson et al. Sep 2002 B1
6454760 Vanney Sep 2002 B2
6454794 Knudson et al. Sep 2002 B1
6458092 Gambale et al. Oct 2002 B1
6458140 Akin et al. Oct 2002 B2
6458323 Boekstegers Oct 2002 B1
6464709 Shennib et al. Oct 2002 B1
6475226 Belef et al. Nov 2002 B1
6475244 Herweck et al. Nov 2002 B2
6482220 Mueller Nov 2002 B1
6491689 Ellis et al. Dec 2002 B1
6491707 Makower et al. Dec 2002 B2
6506408 Palasis Jan 2003 B1
6508783 DeVore Jan 2003 B2
6508824 Flaherty et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6514271 Evans et al. Feb 2003 B2
6517558 Gittings et al. Feb 2003 B2
6524323 Nash et al. Feb 2003 B1
6524324 Mueller et al. Feb 2003 B1
6528444 Kondoh et al. Mar 2003 B1
6533779 Kinsella et al. Mar 2003 B2
6544220 Shuman et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6559132 Holmer May 2003 B1
6561998 Roth et al. May 2003 B1
6565528 Mueller May 2003 B1
6565594 Herweck et al. May 2003 B1
6569145 Shmulewitz et al. May 2003 B1
6569147 Evans et al. May 2003 B1
6573311 Martakos et al. Jun 2003 B1
6582463 Mowry et al. Jun 2003 B1
6587718 Talpade Jul 2003 B2
6605053 Kamm et al. Aug 2003 B1
6610100 Phelps et al. Aug 2003 B2
6613026 Palasis et al. Sep 2003 B1
6616626 Crank et al. Sep 2003 B2
6632470 Morra et al. Oct 2003 B2
6641610 Briefs et al. Nov 2003 B2
6651670 Rapacki et al. Nov 2003 B2
6669691 Taimisto Dec 2003 B1
6669709 Cohn et al. Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6685716 Flaherty et al. Feb 2004 B1
20010000041 Selmon et al. Mar 2001 A1
20010004683 Gambale et al. Jun 2001 A1
20010004690 Gambale et al. Jun 2001 A1
20010004699 Gittings et al. Jun 2001 A1
20010008969 Evans et al. Jul 2001 A1
20010012924 Milo et al. Aug 2001 A1
20010012948 Vanney Aug 2001 A1
20010014813 Saadat et al. Aug 2001 A1
20010016700 Eno et al. Aug 2001 A1
20010018596 Selmon et al. Aug 2001 A1
20010020172 Selmon et al. Sep 2001 A1
20010025643 Foley Oct 2001 A1
20010027287 Shmulewitz et al. Oct 2001 A1
20010029385 Shennib et al. Oct 2001 A1
20010034547 Hall et al. Oct 2001 A1
20010037117 Gambale et al. Nov 2001 A1
20010037149 Wilk Nov 2001 A1
20010039426 Makower et al. Nov 2001 A1
20010039445 Hall et al. Nov 2001 A1
20010041902 Lepulu et al. Nov 2001 A1
20010044631 Akin et al. Nov 2001 A1
20010047165 Makower et al. Nov 2001 A1
20010047197 Foley Nov 2001 A1
20010049523 DeVore et al. Dec 2001 A1
20010053932 Phelps et al. Dec 2001 A1
20020002349 Flaherty et al. Jan 2002 A1
20020004662 Wilk Jan 2002 A1
20020004663 Gittings et al. Jan 2002 A1
20020007138 Wilk et al. Jan 2002 A1
20020029079 Kim et al. Mar 2002 A1
20020032476 Gambale et al. Mar 2002 A1
20020032478 Boekstegers et al. Mar 2002 A1
20020033180 Solem Mar 2002 A1
20020049486 Knudson et al. Apr 2002 A1
20020049495 Kutryk et al. Apr 2002 A1
20020058897 Renati May 2002 A1
20020062146 Makower et al. May 2002 A1
20020065478 Knudson et al. May 2002 A1
20020072699 Knudson et al. Jun 2002 A1
20020072758 Reo et al. Jun 2002 A1
20020077566 Laroya et al. Jun 2002 A1
20020077654 Javier, Jr. et al. Jun 2002 A1
20020082546 Crank et al. Jun 2002 A1
20020092535 Wilk Jul 2002 A1
20020092536 LaFontaine et al. Jul 2002 A1
20020095110 Vanney et al. Jul 2002 A1
20020095111 Tweden et al. Jul 2002 A1
20020099392 Mowry et al. Jul 2002 A1
20020099404 Mowry Jul 2002 A1
20020100484 Wolf et al. Aug 2002 A1
20020103459 Sparks et al. Aug 2002 A1
20020103495 Cole Aug 2002 A1
20020103534 Vanney et al. Aug 2002 A1
20020111644 Shuman et al. Aug 2002 A1
20020111672 Kim et al. Aug 2002 A1
20020123698 Garibotto et al. Sep 2002 A1
20020123786 Gittings et al. Sep 2002 A1
20020138087 Shennib et al. Sep 2002 A1
20020143285 Eno et al. Oct 2002 A1
20020143289 Ellis et al. Oct 2002 A1
20020143347 Cole et al. Oct 2002 A1
20020144696 Sharkawy et al. Oct 2002 A1
20020161383 Akin et al. Oct 2002 A1
20020161424 Rapacki et al. Oct 2002 A1
20020165479 Wilk Nov 2002 A1
20020165606 Wolf et al. Nov 2002 A1
20020179098 Makower et al. Dec 2002 A1
20020183716 Herweck et al. Dec 2002 A1
20020193782 Ellis et al. Dec 2002 A1
20030015816 Rapacki et al. Jan 2003 A1
20030018379 Knudson et al. Jan 2003 A1
20030044315 Boekstegers Mar 2003 A1
20030045828 Wilk Mar 2003 A1
20030055371 Wolf et al. Mar 2003 A1
20030062650 Martakos et al. Apr 2003 A1
20030073973 Evans et al. Apr 2003 A1
20030078561 Gambale et al. Apr 2003 A1
20030078562 Makower et al. Apr 2003 A1
20030100920 Akin et al. May 2003 A1
20030105514 Phelps et al. Jun 2003 A1
20030120195 Milo et al. Jun 2003 A1
20030120259 Mickley Jun 2003 A1
20030125798 Martin Jul 2003 A1
20030163198 Morra et al. Aug 2003 A1
20030181938 Roth et al. Sep 2003 A1
20030195458 Phelps et al. Oct 2003 A1
20030204160 Kamm et al. Oct 2003 A1
20030212413 Wilk Nov 2003 A1
20030216679 Wolf et al. Nov 2003 A1
20030236542 Makower Dec 2003 A1
20040006298 Wilk Jan 2004 A1
20040006301 Sell et al. Jan 2004 A1
20040015225 Kim et al. Jan 2004 A1
Foreign Referenced Citations (201)
Number Date Country
0 732 088 Sep 1996 EP
0 792 624 Sep 1997 EP
0 797 957 Oct 1997 EP
0 797 958 Oct 1997 EP
0 799 604 Oct 1997 EP
0 801 928 Oct 1997 EP
0 824 903 Feb 1998 EP
0 829 239 Mar 1998 EP
0 836 834 Apr 1998 EP
0 853 921 Jul 1998 EP
0 858 779 Aug 1998 EP
0 876 796 Nov 1998 EP
0 876 803 Nov 1998 EP
0 815 798 Jan 1999 EP
0 888 750 Jan 1999 EP
0 895 752 Feb 1999 EP
0 903 123 Mar 1999 EP
0 904 745 Mar 1999 EP
0 934 728 Aug 1999 EP
0 955 017 Nov 1999 EP
0 955 019 Nov 1999 EP
0 962 194 Dec 1999 EP
1 020 166 Jul 2000 EP
1 027 870 Aug 2000 EP
1 027 878 Aug 2000 EP
1 088 564 Apr 2001 EP
1 097 676 May 2001 EP
1 166 721 Jan 2002 EP
0 959 815 Dec 2002 EP
1 112 097 Jun 2003 EP
2316322 Oct 1998 GB
WO 9416629 Aug 1994 WO
94169629 Aug 1994 WO
WO 9635469 Nov 1996 WO
WO 9639962 Dec 1996 WO
WO 9639964 Dec 1996 WO
WO 9639965 Dec 1996 WO
9713463 Apr 1997 WO
9713471 Apr 1997 WO
WO 9718768 May 1997 WO
9727893 Aug 1997 WO
9727897 Aug 1997 WO
9727898 Aug 1997 WO
WO 9727898 Aug 1997 WO
9732551 Sep 1997 WO
WO 9741916 Nov 1997 WO
9741916 Nov 1997 WO
WO 9743961 Nov 1997 WO
WO 9802099 Jan 1998 WO
WO 9803118 Jan 1998 WO
9806356 Feb 1998 WO
9808456 Mar 1998 WO
9810714 Mar 1998 WO
9816161 Apr 1998 WO
WO 9817185 Apr 1998 WO
WO 9819607 May 1998 WO
WO 9824373 Jun 1998 WO
WO 9825533 Jun 1998 WO
WO 9838916 Sep 1998 WO
WO 9838925 Sep 1998 WO
WO 9838939 Sep 1998 WO
WO 9838941 Sep 1998 WO
WO 9839038 Sep 1998 WO
WO 9844869 Oct 1998 WO
9846115 Oct 1998 WO
9846119 Oct 1998 WO
WO 9849964 Nov 1998 WO
WO 9853759 Dec 1998 WO
WO 9855027 Dec 1998 WO
WO 9857590 Dec 1998 WO
WO 9857591 Dec 1998 WO
WO 9857592 Dec 1998 WO
9808624 Feb 1999 WO
WO 9907296 Feb 1999 WO
WO 9915220 Apr 1999 WO
WO 9917671 Apr 1999 WO
9917683 Apr 1999 WO
9921490 May 1999 WO
WO 9921510 May 1999 WO
WO 9922655 May 1999 WO
WO 9922658 May 1999 WO
9925273 May 1999 WO
WO 9927985 Jun 1999 WO
WO 9932051 Jul 1999 WO
WO 9935977 Jul 1999 WO
WO 9935979 Jul 1999 WO
WO 9935980 Jul 1999 WO
9936000 Jul 1999 WO
9936001 Jul 1999 WO
WO 9937218 Jul 1999 WO
9938459 Aug 1999 WO
WO 9940853 Aug 1999 WO
9940868 Aug 1999 WO
WO 9940963 Aug 1999 WO
WO 9944524 Sep 1999 WO
WO 9947071 Sep 1999 WO
WO 9947078 Sep 1999 WO
WO 9948427 Sep 1999 WO
9948545 Sep 1999 WO
WO 9948549 Sep 1999 WO
9949790 Oct 1999 WO
9949793 Oct 1999 WO
9949910 Oct 1999 WO
9951162 Oct 1999 WO
9952481 Oct 1999 WO
9953863 Oct 1999 WO
9955406 Nov 1999 WO
9662430 Dec 1999 WO
9960941 Dec 1999 WO
0009195 Feb 2000 WO
WO 0010623 Mar 2000 WO
0012029 Mar 2000 WO
WO 0013722 Mar 2000 WO
0015146 Mar 2000 WO
0015147 Mar 2000 WO
0015148 Mar 2000 WO
0015149 Mar 2000 WO
0015275 Mar 2000 WO
0018302 Apr 2000 WO
WO 0018323 Apr 2000 WO
WO 0018325 Apr 2000 WO
WO 0018326 Apr 2000 WO
WO 0018331 Apr 2000 WO
WO 0018462 Apr 2000 WO
0021436 Apr 2000 WO
0021461 Apr 2000 WO
0021463 Apr 2000 WO
0024449 May 2000 WO
0033725 Jun 2000 WO
WO 0035376 Jun 2000 WO
WO 0036997 Jun 2000 WO
0041632 Jul 2000 WO
0041633 Jul 2000 WO
WO 0043051 Jul 2000 WO
0045711 Aug 2000 WO
WO 0045886 Aug 2000 WO
WO 0049952 Aug 2000 WO
WO 0049954 Aug 2000 WO
WO 0049956 Aug 2000 WO
WO 0054660 Sep 2000 WO
WO 0054661 Sep 2000 WO
WO 0056224 Sep 2000 WO
WO 0056225 Sep 2000 WO
0056387 Sep 2000 WO
0066007 Nov 2000 WO
0066009 Nov 2000 WO
0066035 Nov 2000 WO
WO 0069345 Nov 2000 WO
WO 0069504 Nov 2000 WO
0071195 Nov 2000 WO
WO 0108566 Feb 2001 WO
WO 0108602 Feb 2001 WO
WO 0108602 Feb 2001 WO
0110340 Feb 2001 WO
0110341 Feb 2001 WO
0110347 Feb 2001 WO
0110348 Feb 2001 WO
0110349 Feb 2001 WO
WO 0110350 Feb 2001 WO
0117440 Mar 2001 WO
0117456 Mar 2001 WO
WO 0123016 Apr 2001 WO
WO 0126562 Apr 2001 WO
WO 0141657 Jun 2001 WO
0149187 Jul 2001 WO
WO 0154625 Aug 2001 WO
0160427 Aug 2001 WO
WO 0168158 Sep 2001 WO
WO 0170133 Sep 2001 WO
WO 0172239 Oct 2001 WO
0178801 Oct 2001 WO
0182803 Nov 2001 WO
0182837 Nov 2001 WO
WO 0202163 Jan 2002 WO
0211647 Feb 2002 WO
WO 0211807 Feb 2002 WO
WO 0213698 Feb 2002 WO
WO 0213699 Feb 2002 WO
WO 0213703 Feb 2002 WO
WO 0213704 Feb 2002 WO
WO 0224108 Mar 2002 WO
WO 0224247 Mar 2002 WO
WO 0224248 Mar 2002 WO
WO 0226310 Apr 2002 WO
WO 0226462 Apr 2002 WO
WO 0230325 Apr 2002 WO
WO 0230326 Apr 2002 WO
WO 0230330 Apr 2002 WO
WO 0232330 Apr 2002 WO
WO 0234323 May 2002 WO
WO 0245598 Jun 2002 WO
WO 0249695 Jun 2002 WO
WO 02056937 Jul 2002 WO
WO 02058567 Aug 2002 WO
WO 02058591 Aug 2002 WO
WO 02060509 Aug 2002 WO
WO 02062265 Aug 2002 WO
WO 02064020 Aug 2002 WO
WO 02091958 Nov 2002 WO
WO 03028522 Apr 2003 WO
WO 2004000170 Dec 2003 WO
Related Publications (1)
Number Date Country
20020045928 A1 Apr 2002 US
Provisional Applications (1)
Number Date Country
60201732 May 2000 US